Perone Thomas Michael 4
4 · Ovid Therapeutics Inc. · Filed Oct 13, 2020
Insider Transaction Report
Form 4
Perone Thomas Michael
SVP, General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-10-11+20,000→ 20,000 totalExercise: $5.65Exp: 2030-10-10→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]50% of the shares subject to the Stock Option will vest and become exercisable on October 11, 2021 and the remaining shares will vest in 12 equal installments thereafter, subject to the Reporting Person's continued service through each such date.